Loading clinical trials...
Loading clinical trials...
In France, the Afssaps is the body in charge of the evaluation of pharmacodependance. In order to fulfil its mission, the Afssaps has created a network of 11 Centres for Evaluation and Information on Pharmacodependance (CEIP), coordinated by the Drugs and Psychotropics Unit. Pharmacodependence notifications issued by professionals are collected by each Centre which evaluates them. Nantes' CEIP created an original tool to harmonize case reporting and make it possible to homogeneously evaluate the seriousness of pharmacodependence cases as each CEIP had his own way of analysing his cases. The aim of this study is to assess this tool.
Age
All ages
Sex
ALL
Healthy Volunteers
No
Hôpital Pellegrin
Bordeaux, France
CHRU de Caen
Caen, France
CHU de Grenoble
Grenoble, France
Centre Antipoison - Centre de Pharmacovigilance
Lyon, France
Hôpital Salvator
Marseille, France
Hôpital Lapeyronie
Montpellier, France
CHU de Nancy
Nancy, France
CHU de Nantes
Nantes, France
Hôpital Fernand Widal
Paris, France
Faculté de médecine
Toulouse, France
Start Date
January 3, 2008
Primary Completion Date
June 14, 2011
Completion Date
September 15, 2013
Last Updated
September 14, 2021
3,180
ACTUAL participants
Lead Sponsor
Nantes University Hospital
NCT01036581
NCT05877742
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT05361603